
Sign up to save your podcasts
Or


In this podcast, Kim Birtcher, Seth Martin, Donald Lloyd-Jones, and Lynne Braun discuss what optimal lipid therapy and management look like in a post-ezetimibe world. They answer patient and colleague questions about lowering low-density lipoprotein (LDL) and debate if LDL can ever be too low. This is a rebroadcast from the clinical focus session at ACC.19.
By American College of Cardiology4.4
3737 ratings
In this podcast, Kim Birtcher, Seth Martin, Donald Lloyd-Jones, and Lynne Braun discuss what optimal lipid therapy and management look like in a post-ezetimibe world. They answer patient and colleague questions about lowering low-density lipoprotein (LDL) and debate if LDL can ever be too low. This is a rebroadcast from the clinical focus session at ACC.19.

137 Listeners

320 Listeners

497 Listeners

169 Listeners

885 Listeners

290 Listeners

3,343 Listeners

140 Listeners

1,156 Listeners

61 Listeners

195 Listeners

90 Listeners

364 Listeners

253 Listeners

430 Listeners